| # | Drug | Count |
|---|---|---|
| 0 | PENTOSAN POLYSULFATE SODIUM | 607 |
| 1 | GABAPENTIN | 54 |
| 2 | LISINOPRIL | 42 |
| 3 | OMEPRAZOLE MAGNESIUM | 42 |
| 4 | OMEPRAZOLE | 39 |
| 5 | PANTOPRAZOLE | 36 |
| 6 | METOPROLOL | 28 |
| 7 | METOPROLOL TARTRATE | 28 |
| 8 | ESTRADIOL | 27 |
| 9 | ALPRAZOLAM | 26 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PENTOSAN POLYSULFATE SODIUM | 607 | 0.0876 |
| 1 | BENZHYDROCODONE AND ACETAMINOPHEN | 1 | 0.0476 |
| 2 | SUMATRIPTAN AND NAPROXEN SODIUM | 1 | 0.0455 |
| 3 | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, PHENYL SALICYLATE, METHYLENE BLUE AND HYOSCYAMINE SULFATE | 1 | 0.0250 |
| 4 | TRYPAN BLUE | 1 | 0.0217 |
| 5 | HYOSCYAMINE SULFATE, METHENAMINE, METHYLENE BLUE, PHENYL SALICYLATE, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | 1 | 0.0111 |
| 6 | CHLOROPROCAINE HYDROCHLORIDE OPHTHALMIC GEL | 1 | 0.0093 |
| 7 | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, METHYLENE BLUE, AND HYOSCYAMINE SULFATE | 1 | 0.0090 |
| 8 | DIMETHYL SULFOXIDE | 2 | 0.0082 |
| 9 | POLYETHYLENE GLYOCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE | 1 | 0.0081 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 70 |
| 1 | Benzodiazepine [EPC] | 61 |
| 2 | Proton Pump Inhibitor [EPC] | 49 |
| 3 | Estrogen [EPC] | 45 |
| 4 | Corticosteroid [EPC] | 40 |
| 5 | HMG-CoA Reductase Inhibitor [EPC] | 29 |
| 6 | Anti-epileptic Agent [EPC] | 22 |
| 7 | Dihydropyridine Calcium Channel Blocker [EPC] | 22 |
| 8 | Calcium Channel Blocker [EPC] | 20 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 19 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Melanocortin 4 Receptor Agonist [EPC] | 1 | 0.0035 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 6 | 0.0029 |
| 2 | Nucleoside Analog Antifungal [EPC] | 1 | 0.0007 |
| 3 | Provitamin D2 Compound [EPC] | 19 | 0.0006 |
| 4 | Nitrofuran Antibacterial [EPC] | 10 | 0.0006 |
| 5 | Non-Standardized Fungal Allergenic Extract [EPC] | 1 | 0.0005 |
| 6 | Chloride Channel Activator [EPC] | 4 | 0.0004 |
| 7 | Cholinergic Muscarinic Antagonist [EPC] | 15 | 0.0004 |
| 8 | Monoamine Oxidase Inhibitor [EPC] | 1 | 0.0003 |
| 9 | Carbonic Anhydrase Inhibitor [EPC] | 6 | 0.0003 |